메뉴 건너뛰기




Volumn 8, Issue 5, 2000, Pages 254-256

Targeting leukemia cells with Gemtuzumab Ozogamicin

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; ANTINEOPLASTIC ANTIBIOTIC; CALICHEAMICIN; CD33 ANTIGEN; CMA 676; CYTARABINE; ETOPOSIDE; GEMTUZUMAB; GRANULOCYTE COLONY STIMULATING FACTOR; MITOXANTRONE; MONOCLONAL ANTIBODY; MYLOTARG; UNCLASSIFIED DRUG;

EID: 0033778437     PISSN: 10654704     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-5394.2000.85010.x     Document Type: Review
Times cited : (5)

References (14)
  • 3
    • 0007562266 scopus 로고    scopus 로고
    • US Food and Drug Administration. Proposed Text of Labeling for the Drug-Annotated Mylotarg. Paper available. First accessed
    • (2000)
  • 6
    • 0007562771 scopus 로고    scopus 로고
    • Calicheamicin-conjugated humanized Anti CD33 monoclonal antibody shows non-apoptotic cytocidal effect on CD-33 positive cell lines, but is inactive on p-glycoprotein-expressing sublines
    • www.hematology.org; accessed 5/1/2000
    • (1999) Proc Annu Meet Am Soc Hematol , pp. 2282
    • Naito, K.1    Takeshita, A.2    Shigeno, K.3
  • 10
    • 0007559052 scopus 로고    scopus 로고
    • US Food and Drug Administration. Gemtuzumab zogamicin: summary for presentation to the FDA's Oncologic Drug Advisory Committee. First accessed
    • (2000)
  • 11
    • 17344366634 scopus 로고    scopus 로고
    • Superiority of high-dose over intermediate-dose cytosine arabinoside in the treatment of patients with high-risk acute myeloid leukemia: Results of an age-adjusted prospective randomized comparison
    • (1998) Leukemia , vol.12 , pp. 1049-1055
    • Kern, W.1    Aul, C.2    Maschmeyer, G.3
  • 12
    • 0028077347 scopus 로고
    • A phase III trial of high-dose cytosine arabinoside with or without etoposide in relapsed and refractory acute myelogenous leukemia
    • A Southeastern Cancer Study Group trial
    • (1994) Leukemia , vol.8 , pp. 1847-1853
    • Vogler, W.R.1    McCarley, D.L.2    Stagg, M.3
  • 13
    • 0028256428 scopus 로고
    • A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia
    • (1994) Blood , vol.83 , pp. 2086-2092
    • Ohno, R.1    Naoe, T.2    Karamaru, A.3
  • 14
    • 0033566795 scopus 로고    scopus 로고
    • Phase I study of I-131-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome
    • (1999) Blood , vol.94 , pp. 1237-1247
    • Mathews, D.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.